Monthly orthopedics and trauma bulletin — October 5, 2026

Period covered: September 5 to October 5, 2026. A light month for large trials: we include 10 verified items rather than padding. In arthroplasty, the only high-impact finding was the UK registry analysis of robotic surgery; we found no verifiable periprosthetic joint infection studies from this period. Outside North America and Western Europe there were three verifiable items (Australia, Taiwan and Japan); in Latin America and the Caribbean we found no verifiable clinical publications from the period, only society meeting announcements.

Arthroplasty and reconstructive surgery

1. Robotic hip and knee arthroplasty does not reduce overall revision risk

[Publication] [United Kingdom]
Two National Joint Registry analyses published in The BMJ on September 30 using target trial emulation: 666,283 hip arthroplasties (10,203 robotic) and 697,145 knee arthroplasties (22,111 robotic) performed between 2018 and 2024, with a mean follow-up of 2.5 years. There were no differences in implant survival, all-cause or cause-specific revision, or intraoperative complications. The one exception: a lower risk of revision for malposition in robotic hips.
Why it matters: this is the largest registry evidence to date, arriving as robots cost about £1 million plus £1,000–2,500 per case; it is observational, short-term and lacks functional outcomes, but for Dominican hospitals considering a robot purchase, the "fewer revisions" argument does not hold in the short term.
https://doi.org/10.1136/bmj-2026-100709
https://doi.org/10.1136/bmj-2026-100691
https://www.qmul.ac.uk/news/latest-news/2026/medicine-and-dentistry/fmd/robotic-hip-and-knee-surgery-fails-to-cut-overall-risk-of-repeat-surgery.html

Trauma and fractures

2. Surgical delay in hip fracture: no signal at 3 months, a signal at 1 year

[Publication] [Norway]
Single-center cohort with prospectively collected data (European Journal of Trauma and Emergency Surgery, online September 23): 4,136 hip fractures from 2015 to 2023. At 3 months (primary endpoint), mortality was numerically higher with delays beyond 12 hours, without statistical significance. At 1 year, waiting 12–24 hours was associated with an adjusted OR of 1.38, and more than 48 hours with 1.80.
Why it matters: it supports early surgery, but the authors themselves urge caution: it is observational, the signal appears only in the most confounding-prone endpoint, and it contrasts with the HIP ATTACK trial; in settings where delay stems from lack of operating room time or implants, the organizational message still holds.
https://link.springer.com/article/10.1007/s00068-026-03351-w

3. Cold, more than snow, is associated with hip fractures in older adults

[Publication] [Japan]
Shinshu University reported on October 1 a study, published in an international journal, of proximal femoral fractures in older adults in Nagano Prefecture: low temperature outweighed snow accumulation as an environmental factor. The release does not give sample size or figures.
Why it matters: an epidemiological signal, not practice-changing data; applicability to the Caribbean is limited, but it is a reminder that fall risk has preventable environmental components. (source in Japanese)
https://www.shinshu-u.ac.jp/topics/2026/10/post-783.html

Spine, shoulder, sports medicine and arthroscopy

4. Supervised exercise for persistent symptoms after ACL reconstruction

[Clinical trial] [Australia]
La Trobe University randomized trial published in Annals of Internal Medicine on September 29: 184 adults aged 18 to 40 with persistent knee problems 1 to 3 years after anterior cruciate ligament reconstruction. Four months of progressive physiotherapist-supervised exercise, compared with a single education session, improved symptoms and muscle strength without cartilage deterioration.
Why it matters: it supports prescribing structured late rehabilitation for patients who "never quite recover"; follow-up is short and it does not yet show prevention of early osteoarthritis, which affects about half of these patients within 10 years.
https://www.acpjournals.org/doi/10.7326/ANNALS-26-02460

5. Lumbar fusion vs. conservative care in selected discogenic pain

[Clinical trial] [Sweden]
Randomized trial published in Interdisciplinary Neurosurgery (September 2026): 74 patients with chronic segmental/discogenic low back pain, fusion plus exercise and cognitive behavioral therapy (n=37) vs. exercise and cognitive behavioral therapy alone (n=37). At 1 year, 81% of surgical patients reported less pain vs. 16%; ODI fell from 45 to 17 with surgery and from 46 to 44 without; VAS went from 66 to 7 vs. 64 to 74.
Why it matters: striking results, but the trial is small, highly selected, unblinded by necessity and contradicts earlier fusion trials in discogenic pain; it does not justify broadening fusion indications.
https://www.sciencedirect.com/science/article/pii/S2214751926001246

6. Synergy cervical disc vs. discectomy and fusion at 2 years

[Industry] [United States]
The manufacturer presented at the Society for Minimally Invasive Spine Surgery annual forum (press release September 17) data from its multicenter IDE study: 175 disc patients vs. 192 propensity-matched historical ACDF controls. Composite clinical success at 24 months: 87.1% vs. 56.6% (p<0.0001); mean neck pain 15.6 vs. 30.2 out of 100.
Why it matters: the control group is historical, not randomized, and the data come from the company; useful device information, not proof of superiority.
https://orthospinenews.com/2026/09/17/synergy-spine-solutions-highlights-superior-two-year-clinical-outcomes-for-fda-approved-synergy-disc-at-society-for-minimally-invasive-spine-surgery/

Osteoporosis, rehabilitation and pediatric orthopedics

7. The osteoporosis treatment gap depends on the type of surgery, not on bone density

[Publication] [Taiwan]
Retrospective tertiary-center cohort (Journal of Clinical Medicine, October 4): 6,171 operations in 5,739 patients from 2015 to 2025. Within 1 year, osteoporosis treatment was started in 46.9% after vertebroplasty, 43.1% after hip fracture fixation, 33.0% after hip arthroplasty, 17.4% after lumbar fusion and 7.2% after total knee arthroplasty. The gap persisted among 871 patients with T ≤ −2.5 (48.2% vs. 7.5%); among untreated patients, each one-unit lower T-score was associated with a fracture HR of 1.25.
Why it matters: although shaped by Taiwan's reimbursement rules, it reflects a universal problem: the osteoporotic elective patient leaves the operating room untreated; a fracture liaison service or a preoperative bone health protocol is applicable in the Dominican Republic.
https://www.mdpi.com/2077-0383/15/19/7683

8. microRNA test predicting scoliosis progression receives FDA Breakthrough Device designation

[Regulatory FDA] [United States]
On September 29, VB Spine announced Breakthrough Device designation for ScolimiR-3D, a blood test using a six-microRNA panel to classify progression risk in adolescent idiopathic scoliosis. The underlying study, in Scientific Reports, included 116 patients and reported 100% sensitivity and specificity in validation.
Why it matters: designation is not approval; perfect figures in a small sample require independent external validation before they influence bracing or surgical decisions.
https://biospace.com/press-releases/vb-spine-announces-fda-breakthrough-device-designation-for-new-blood-test-designed-to-identify-patients-at-risk-for-scoliosis-progression

Cross-cutting

9. DePuy Synthes unveils plates, a remotely monitored fixator and AI guidance at OTA 2026

[Industry] [United States]
At the Orthopaedic Trauma Association annual meeting (Nashville, September 23), the company showed four VOLT plating systems built on CT-derived anatomical data, the Bluetooth-enabled MAXFRAME AUTOSTRUT fixator (already marketed in the U.S.) and VELY, a tracker-free AI-assisted intraoperative 3D guidance system expected in 2027.
Why it matters: the announcement includes no clinical data or regulatory clearance dates; this is market information, not evidence.
https://www.news-medical.net/news/20260923/DePuy-Synthes-showcases-next-generation-trauma-innovations-at-OTA-2026.aspx

10. Ireland proposes a commission of investigation into pediatric scoliosis and hip dysplasia care

[Health policy] [Ireland]
On September 28 the scoping report was published recommending a commission of investigation, largely in private, into scoliosis, spina bifida and hip dysplasia care at Children's Health Ireland from 2019 to 2025, including spinal surgery waiting lists. Family advocacy groups object to the format and start date.
Why it matters: not a clinical guideline but a health policy decision; a reminder that delays in pediatric spine surgery are a patient safety issue, including in systems with waiting lists like ours.
https://irishtimes.com/opinion/editorials/2026/09/28/the-irish-times-view-on-the-scoliosis-inquiry-families-must-be-heard

Upcoming meetings and dates

• NASS 2026 (North American Spine Society): October 14–17, San Antonio, Texas. https://www.spine.org/am
• World Osteoporosis Day: October 20.
• Later: XLVII International Congress of the Dominican Society of Orthopedics and Traumatology, December 3–6, Miches, honoring Dr. José Leonidas Benzán, with SLARD as guest society. https://diariosalud.do/congreso-ortopedia-dr-jose-leonidas-benzan

Curated by Aura Celeste Vascular · Medical Bulletins

Monthly orthopedics and trauma bulletin — October 5, 2026

10 verified items from the past month, from The BMJ, Annals of Internal Medicine, European Journal of Trauma and Emergency Surgery, Journal of Clinical Medicine, and regulatory and society announcements.

Three worth your time:
• Robotic arthroplasty (BMJ, UK National Joint Registry, more than 1.3 million joints): no reduction in overall revision risk at 2.5 years; fewer malposition revisions in hips only. Observational, short follow-up.
• Supervised exercise after ACL reconstruction (Australian RCT, n=184): better symptoms and strength at 4 months vs. one education session, with no cartilage deterioration. Long-term OA prevention unproven.
• Osteoporosis gap after surgery (Taiwan, 6,171 operations): 46.9% treated after vertebroplasty, only 7.2% after knee arthroplasty. Single center.

Full bulletin, with critical appraisal of every study and links to primary sources:
https://boletinesmedicos.com/en/ortopedia/2026-10-05.html

#Orthopedics #OrthoTwitter #Arthroplasty #Osteoporosis #SportsMedicine

Robotic hip and knee arthroplasty: no drop in overall revisions (BMJ, >1.3M joints). Supervised exercise after ACL reconstruction improves symptoms and strength (RCT, n=184). October bulletin: https://boletinesmedicos.com/en/ortopedia/2026-10-05.html